首页 | 本学科首页   官方微博 | 高级检索  
检索        

促性腺激素释放激素激动剂治疗子宫肌瘤近期疗效观察
引用本文:刘惜时,张惜阴.促性腺激素释放激素激动剂治疗子宫肌瘤近期疗效观察[J].实用妇产科杂志,2002,18(3):175-176.
作者姓名:刘惜时  张惜阴
作者单位:复旦大学附属妇产科医院,上海,200011
摘    要:目的 :探讨促性腺激素释放激素激动剂 (Gn RH- a)在治疗子宫肌瘤中的作用。方法 :75例子宫肌瘤患者用Gn RH- a皮下注射 3个月 ,比较治疗前后症状、子宫和肌瘤的体积、血生殖激素水平、子宫血流阻力变化。结果 :子宫及肌瘤体积较治疗前缩小 (P<0 .0 5 )。肌瘤体积缩小≥ 2 0 %以上的病例 6 5例 (86 .6 % ) ,血生殖激素水平明显下降 ,子宫动脉及肌瘤血管阻力指数增加 (P<0 .0 5 )。结论 :Gn RH- a通过降低内生殖激素水平 ,减少子宫血流而发挥其治疗子宫肌瘤的作用。

关 键 词:促性腺激素释放激素激动剂  子宫肌瘤  血管阻力
文章编号:1003-6946(2002)03-175-02
修稿时间:2002年1月18日

Observation of the Effect of Gonadotrophin Releasing Hormone Agonist in the Treatment of Fibomyoma
LIU Xi shi,ZHANG Xi yin.Observation of the Effect of Gonadotrophin Releasing Hormone Agonist in the Treatment of Fibomyoma[J].Journal of Practical Obstetrics and Gynecology,2002,18(3):175-176.
Authors:LIU Xi shi  ZHANG Xi yin
Abstract:Objectives:To study the role of gonadotrophin releasing hormone agonist in the treatment of fibomyoma. Methods: 75 patients suffered urerine leiomyoma were teated by injection of GnRH a 3.75 mg each month subcutaneously for three months.Comparation was made on the change of size of uterus and myoma,the level of serum reproductive hormone and blood flow of uterus.Results: The clinical symptoms were improved obviously after treatment.The size of leiomyoma and more in decreased 20.0% was 86.6%(65/75)of patients,( P <0.05).The level of serum reproductive hormone is reduced obviously.Resistant index of artery of uterus and myoma were increased( P <0.05).Conclusion: GnRH a is an effect through reduced of level about reproductive hormone and blood flow of uterus.
Keywords:Gonadotrophin releasing hormone agonist  Leiomyoma  Resistant Index of artery of uterus
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号